We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Music Therapy on Patients Undergoing Intravitreal Injections

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00702039
First Posted: June 19, 2008
Last Update Posted: October 17, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Yale University
  Purpose

Multiple studies in various specialties, including ophthalmology, are reported in the literature that show that playing music during a procedure (dubbed music therapy) increases patient satisfaction and may reduce patient anxiety and stress levels.

There is no study in the literature that assesses the effects of listening to music in patients undergoing intravitreal injections. This study aims to assess whether listening to music improves patient satisfaction or reduces their anxiety levels in subjects undergoing intravitreal injections.


Condition Intervention
Intravitreal Injections Patient Satisfaction Patient Anxiety Other: No Music Other: Music Therapy

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Effect of Music Therapy on Patients Undergoing Intravitreal Injections

Resource links provided by NLM:


Further study details as provided by Yale University:

Primary Outcome Measures:
  • This study aims to assess what affects music therapy has on patients receiving intravitreal injections. The subject will take a Satisfaction Survey after the procedure and an Anxiety Survey before and after the injection. [ Time Frame: Before and after the subject's intravitreal injection. ]

Enrollment: 50
Study Start Date: February 2007
Study Completion Date: June 2011
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Those patients receiving intravitreal injections who will be listening to classical music during injection.
Other: Music Therapy
Classical music being played during intravitreal injection.
2
Those patients receiving intravitreal injections who will not be listening to any music during injection.
Other: No Music
No music will be played in patients in arm 2 of the study.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients receiving intravitreal injections seen at the Yale Eye Center.
Criteria

Inclusion Criteria:

  • Those patients at least 18 years old already scheduled for intravitreal injections.

Exclusion Criteria:

  • Those patients not interested in participating in the study or not capable of filling out the questionnaire secondary to limited mental capability.
  • Non- English speaking subjects will be excluded from the study.
  • Those patients that participated in the study will not be allowed to participate a second time.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00702039


Locations
United States, Connecticut
Yale Eye Center
New Haven, Connecticut, United States, 06510
Sponsors and Collaborators
Yale University
Investigators
Principal Investigator: Ron Adelman, MD Yale University Department of Ophthalmology
  More Information

Responsible Party: Yale University
ClinicalTrials.gov Identifier: NCT00702039     History of Changes
Other Study ID Numbers: HIC# 0702002303
First Submitted: April 1, 2008
First Posted: June 19, 2008
Last Update Posted: October 17, 2017
Last Verified: October 2017